Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.

Shares of Walgreens Boots Alliance (NASDAQ: WBA) pulled back today after the company again ran into trouble with regulators. On Friday, the Department of Justice (DOJ) filed a lawsuit against Walgreens,

Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) fell 12.3% in the morning session after the US Department of Justice accused the company (Walgreens) of filling millions of unlawful opioid prescriptions.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Walgreens Boots Alliance's whale activity within a strike price range from $7.5 to $12.5 in the last 30 days.

Can Walgreens Boots Alliance stock continue rising, or should investors use the stock's recent gain as an opportunity to exit? Let's look at what the pharmacy chain operator said in its latest report to see whether it's time to buy, sell, or hold the ultra-high-yield dividend stock.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) fell by 6% following allegations by the U.S. Justice Department that the pharmacy chain dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (CSA) and the False Claims Act (FCA).

To say that pharmacy retailer Walgreens Boots Alliance ( WBA 3.19%) has been struggling would be a massive understatement. It's coming off a horrendous year in 2024, when its share price crashed by 64%. The stock has been trading around levels it hasn't been at in decades as investors are concerned about the company's future.